亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都醫藥化工科技有限公司  

大陸,港澳臺,北美,南美,東歐,西歐,東南亞,全球

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:楊女士
  • 電話:0531-88682202
  • 郵件:wedochem03@163.com
  • 傳真:0531-88873470
  • QQ:1158262190
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 桿菌肽 1405-87-4
桿菌肽 1405-87-4
單價 100.00 / 公斤對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 1000公斤起訂1公斤
品牌 偉都化工
型號 桿菌肽 1405-87-4
規格 桿菌肽 1405-87-4
過期 長期有效
更新 2013-03-07 08:33
 
詳細信息

桿菌肽 1405-87-4

英文名  Bacitracin
別名  N-[[(4R)-2-[(1S,2S)-1-Amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-alpha-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-alpha-aspartyl-L-asparagine (10.4)-lactam
產品名稱  桿菌肽
 
分子式  C66H103N17O16S
分子量  1422.69
CAS 登錄號  1405-87-4
適于治療癰癤、膿腫、痤瘡、化膿性皮膚病、阿米痢疾、淋球菌和腦膜炎又球菌等感染癥。對腎臟的毒性較大。
 

©2025 濟南偉都醫藥化工科技有限公司 版權所有   技術支持:化工網   訪問量:37712  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |